Innovation in monoclonal anti-Mia production
Keywords:
-Abstract
-
Downloads
References
MNS blood group alleles v5.7. International Society of Blood Transfusion (ISBT). Available from https://www.isbtweb.org › rcibgt.
Reid ME. MNS blood group system: a review. Immunohematology. 2009;25:95-101.
Harmening DM. Modern blood banking and transfusion practice. 4th ed. Baltimore, F.A. Davis Company; 1999.
Issitt PD, Anstee DJ. Applied blood group serology. Durham, N.C.: Montgomery Scientific Publications; 1998.
Bejrachandra S, Nathalang O. Miltenberger subsystem. J Hematol Transfus Med. 2015;25:93-8.
Lomas-Francis C. Miltenberger phenotypes are glycophorin variants : a review. ISBT Sci Ser. 2011;6:296-301.
Kerdkaewngam K, Tubrod J, Tingtoy U. Frequency of MNS hybrid glycophorins in Mi(a+) blood donors at the National Blood Centre, Thai Red Cross Society. J Hematol Transfus Med. 2024;34:27-32.
Poole J, King MJ, Mark KH, Liew W, Leong S, Chua M. The Mi III phenotypes among Chinese donors in Hongkong: immunochemical and serological studies. Transfus Med.1991;1:169-75.
Dahr W. Miltenberger subsystem of the MNSs blood group system. Review and outlook. Vox Sang. 1992;62:129-35.
Race RR, Sanger R. Blood group in man. 6th ed. Oxford: Blackwell Scientific Publication; 1975.
Broadberry RE, Lin M. The incidence and significance of anti-"Mia" in Taiwan. Transfusion. 1994;34:349-52.
Chiewsilp P, Yodpornpin W, Cherdchai S. Delayed hemolytic transfusion reaction due to anti-Mia. Thai J Hematol Transfus Med. 1996;6:289-90.
Heathcote DJ, Carroll TE, Flower RL. Sixty year of antibodies to MNS system hybrid glycophorins: what have we learned? Transfus Med Rev. 2011;25:111-24.
Waldvogel S, Natterer J, Canellini G, Truttmann A, Tissort JD. Severe neonatal hyporegenerative anemia due to anti-Vw (anti-MNS9) alloantibody. J Perinat Med. 2009;37:422-4.
Roback JD, Combs MR, Grossman BJ, Hillyer CD, editors. Technical manual. 16th ed. Bethesda, MD: American Association of Blood Banks; 2008:878-82.
Roback JD, Combs MR, Grossman BJ, Hillyer CD, editors. Technical manual. 16th ed. Bethesda, MD: American Association of Blood Banks; 2008:899-902.
Voak D, Sacks S, Alderson T, Takei F, Lennox E, Jarvis J, et al. Monoclonal anti-A from a hybrid-myeloma: evaluating as a blood grouping reagent. Vox Sang. 1980;39:134-40.
Phikulsod S, Poltian R, Kaewkitiroj P, Utid K, Tingtoy U, Tubrod J. Monoclonal anti-A reagent using hybridoma technique prepared by National Blood Centre, Thai Red Cross Society. Thai J Hematol Transfus Med. 1992;2:373-81.
Phikulsod S, Poltian R, Utid K, Kaewkitiroj P, Tingtoy U, Tubrod J. Monoclonal blood grouping reagents prepared by National Blood Centre, Thai Red Cross Society: II the study of the efficacy of the monoclonal anti-B compared with commercial monoclonal reagents and conventional polyclonal anti-B. Thai J Hematol Transfus Med. 1992;2:295-302.
Sakuldamrongpanich T, Tubrod J, Saengkla S, Tingtoy U. Evaluation of anti-D reagents as Rh(D) blood typing. Thai J Hematol Transfus Med. 1999;9:39-48.
Tingtoy U, Phonimit S, Sirpongsanusit A, Makechay S, Sakuldamrongpanich T. Development of monoclonal anti-A production of National Blood Centre, Thai Red Cross Society. Thai J Hematol Transfus Med. 2008;18:11-9.
Kaewmongkol R, Tingtoy U, Sakuldamrongpanich T. Production of blood groupjng monoclonal anti-A, B reagent using hybridoma technique. Thai J Hematol Transfus Med. 2000;10:175-81.
Tingtoy U, Sakuldamrongpanich T, Kaewmongkol R. Production of monoclonal anti-A1 blood group reagent by National Blood Centre, Thai Red Cross Society. Thai J Hematol Transfus Med. 2001;11:21-8.
Kirdkaewgam K, Ponsen S, Phonimit S, Tingtoy U, Phikulsod S. Generating the hybridoma cell line by murine monoclonal hybridoma technology for producing anti-M and anti-N blood group phenotyping reagent. J Hematol Transfus Med. 2014;24:361-9.
Aiemumporn K, Boonhai S, Haewpetch P, Tingtoy U. Characteristics of murine monoclonal anti-H from cell line 5A9 produced by hybridoma technique of the National Blood Centre, Thai Red Cross Society. J Med Biosci. 2021;3:89-96.
Kohler G, Milstein C. Continuous culture of fused cells secreting antibodies of predefined specificity. Nature. 1975;256:495-7.
Grossblatt N, editor. Monoclonal antibody production: a report of the Committee on Methods of Producing Monoclonal Antibodies Institute for Laboratory Animal Research National Research Council. Washington DC: National Academy Press; 1999.
Cho D, Campana D. Expansion and activation of national killer cells for cancer immunotherapy. Korean J Lab Med. 2009;29:89-96.
Linn YC, Hui KM. Cytokine-induced NK-Like T cells: from bench to bedside. J Biomed Biotechnol. 2010;2010:435745.doi: 10.1155/2010/435745.
Zhang US, Yuan FJ, Jia GF, Zhang JF, HU LY, Huang L, et al. CIK cells from patients with HCC possess strong cytotoxicity to multidrug resistant cell line Bel-7402/R. World J Gastroenterol. 2005;11:3339-45.
The Antibody Society. In: Approved antibodies. Jun 27, 2019. Available from: https://www. antibodysociety.org/ the-antibody-society-2024-calendar.
Tingtoy U, Makechay S, Deesin P, Tubrod J. Production of human monoclonal anti-P1 by using hybridoma technique. J Hematol Transfus Med. 2017;27:11-8.
Newell DG, McBride BW, Clark SA. Making monoclonals: a practical beginners’ guide to the production and characterization of monoclonal antibodies against bacteria and viruses. London: Public Health Laboratory Service; 1988:1-43.
Tingtoy U. Review article: production of human monoclonal blood grouping reagents using the hybridoma technique. J Hematol Transfus Med. 2020;30:315-21.
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Journal of Hematology and Transfusion Medicine
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
